SEC Form 4 · accession 0001225208-18-013499
JOHNSON & JOHNSON · JNJ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashley McEvoy
Officer — EVP, WW Chair, Medical Devices
Period of report
Aug 27, 2018
Accepted (ET)
Sep 17, 2018 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000200406
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 27, 2018 | I | 142 | $134.92 | D | 2,215 | I | By 401k |
| Common Stock | holding | — | — | — | 9,476 | D | ||
| Common StockF2 | holding | — | — | — | 300 | I | By ESOP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan.
- F2Shares held by ESOP under the Johnson & Johnson Savings Plan.